279 related articles for article (PubMed ID: 30482227)
1. Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D.
Qiang Z; Zhou ZY; Peng T; Jiang PZ; Shi N; Njoya EM; Azimova B; Liu WL; Chen WH; Zhang GL; Wang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):288. PubMed ID: 30482227
[TBL] [Abstract][Full Text] [Related]
2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
3. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor progression locus 2 protein kinase decreases lipopolysaccharide-induced tumor necrosis factor alpha production due to the inhibition of the tip-associated protein induction in RAW264.7 cells.
Hirata K; Miyashiro M; Ogawa H; Taki H; Tobe K; Sugita T
Biol Pharm Bull; 2010; 33(7):1233-7. PubMed ID: 20606319
[TBL] [Abstract][Full Text] [Related]
5. Luteolin, a novel natural inhibitor of tumor progression locus 2 serine/threonine kinase, inhibits tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells.
Kim JE; Son JE; Jang YJ; Lee DE; Kang NJ; Jung SK; Heo YS; Lee KW; Lee HJ
J Pharmacol Exp Ther; 2011 Sep; 338(3):1013-22. PubMed ID: 21705614
[TBL] [Abstract][Full Text] [Related]
6. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells.
Liu H; Palmer D; Jimmo SL; Tilley DG; Dunkerley HA; Pang SC; Maurice DH
J Biol Chem; 2000 Aug; 275(34):26615-24. PubMed ID: 10851231
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Mishra RR; Belder N; Ansari SA; Kayhan M; Bal H; Raza U; Ersan PG; Tokat ÜM; Eyüpoğlu E; Saatci Ö; Jandaghi P; Wiemann S; Üner A; Cekic C; Riazalhosseini Y; Şahin Ö
Clin Cancer Res; 2018 Apr; 24(8):1987-2001. PubMed ID: 29386221
[No Abstract] [Full Text] [Related]
8. Tpl2 is a key mediator of arsenite-induced signal transduction.
Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z
Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956
[TBL] [Abstract][Full Text] [Related]
9. Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway.
Kar S; Ukil A; Das PK
Eur J Immunol; 2011 Jan; 41(1):116-27. PubMed ID: 21182083
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
11. Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.
Lee WJ; Lan KH; Chou CT; Yi YC; Chen WC; Pan HC; Peng YC; Wang KB; Chen YC; Chao TH; Tien HR; Sheu WH; Sheu ML
Neoplasia; 2013 Sep; 15(9):1036-48. PubMed ID: 24027429
[TBL] [Abstract][Full Text] [Related]
12. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
13. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.
Kamat AM; Sethi G; Aggarwal BB
Mol Cancer Ther; 2007 Mar; 6(3):1022-30. PubMed ID: 17363495
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α suppresses cAMP to disarm human regulatory T cells.
Bacher N; Raker V; Hofmann C; Graulich E; Schwenk M; Baumgrass R; Bopp T; Zechner U; Merten L; Becker C; Steinbrink K
Cancer Res; 2013 Sep; 73(18):5647-56. PubMed ID: 23878189
[TBL] [Abstract][Full Text] [Related]
15. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
Luciano BS; Hsu S; Channavajhala PL; Lin LL; Cuozzo JW
J Biol Chem; 2004 Dec; 279(50):52117-23. PubMed ID: 15466476
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast.
Tao X; He H; Peng J; Xu R; Fu J; Hu Y; Li L; Yang X; Feng X; Zhang C; Zhang L; Yu X; Shen A; Huang K; Fu Q
Pharmacol Res; 2022 Jan; 175():106004. PubMed ID: 34826603
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]